Women's Health MRI

Even radiologists with two years’ experience have statistically inferior diagnostic performance.

Radiation, alongside age and socioeconomic status, is associated with longer diagnosis-to-treatment timelines.

Rethinking CMR during COVID-19; Abdominal Imaging and COVID-19; Mental Health Impacts of COVID-19; African American and Lung Cancer Screening; Plus, African American Women and Disadvantages in Breast Cancer Screening

Women treated with both surgery and radiotherapy for ductal carcinoma in situ fared best.

Combining DBT and synthetic mammography can mean less follow-up imaging for women with non-dense breasts – but not necessarily for women with dense tissue.

A follow-up breast screening MRI ended with a woman from England being treated for viral infection.

Artificial intelligence equivalency in breast cancer screening; diffusion-weighted imaging and breast MRI; CT patterns for EVALI; Emergency Department and CT Scan Declines with COVID-19; and Thoracic Imaging Findings of MIS-C.

Three-way comparison shows alternative protocols to standard echo-planar imaging can produce higher quality images with breast cancer screening.

Abbreviated MRI; Low-Field Cardiac MRI; Contrast-Enhanced Breast Imaging; Obesity and Alzheimer's; and Neuroimaging and COVID-19

Abbreviated MRI protocols can detect and diagnose breast cancer as well as full-protocol MRI.

Limitations in contrast enhancement standardization indicate unenhanced diffusion measurement should be preferred.

MRI screening every 18 months could catch more cancers, add life years in an economically efficient way.

Algorithm can pre-operatively pinpoint metastasis, potentially helping some patients avoid unnecessary surgery.

Relying on patient- or tumor-specific characteristic to recommend pre-operative MRI could result in missed cancers.

Incorporating this imaging catches 11 percent more cancers, potentially affecting surgery plans and outcomes.

Annual MRI screening – with or without mammography – can prevent at least 50 percent of early deaths.

Breast cancers identified between patient screenings are more aggressive and lethal.